Healthcare provider profile · identity verified

Mark Street, MD

Internal Medicine · TULSA, OK · NPI 1982165361

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	476	145
Losartan Potassium	Losartan Potassium	410	120
Gabapentin	Gabapentin	409	101
Amlodipine Besylate	Amlodipine Besylate	380	120
Omeprazole	Omeprazole	294	90
Duloxetine Hcl	Duloxetine Hcl	258	69
Levothyroxine Sodium	Levothyroxine Sodium	250	71
Lisinopril	Lisinopril	247	76
Potassium Chloride	Potassium Chloride	243	70
Metformin Hcl	Metformin Hcl	197	65
Furosemide	Furosemide	163	58
Meloxicam	Meloxicam	159	45
Rosuvastatin Calcium	Rosuvastatin Calcium	158	62
Montelukast Sodium	Montelukast Sodium	157	51
Ezetimibe	Ezetimibe	153	46
Hydrochlorothiazide	Hydrochlorothiazide	150	46
Ozempic	Semaglutide	148	39
Tamsulosin Hcl	Tamsulosin Hcl	146	47
Mounjaro	Tirzepatide	134	24
Pantoprazole Sodium	Pantoprazole Sodium	134	41
Zolpidem Tartrate	Zolpidem Tartrate	133	24
Trazodone Hcl	Trazodone Hcl	132	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	129	50
Metoprolol Succinate	Metoprolol Succinate	129	47
Carvedilol	Carvedilol	124	39
Eliquis	Apixaban	123	30
Albuterol Sulfate Hfa	Albuterol Sulfate	114	41
Fluticasone Propionate	Fluticasone Propionate	112	43
Tizanidine Hcl	Tizanidine Hcl	112	26
Jardiance	Empagliflozin	104	30
Pravastatin Sodium	Pravastatin Sodium	104	36
Allopurinol	Allopurinol	95	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	24
Tramadol Hcl	Tramadol Hcl	93	27
Fluoxetine Hcl	Fluoxetine Hcl	91	26
Spironolactone	Spironolactone	91	33
Simvastatin	Simvastatin	90	29
Metoprolol Tartrate	Metoprolol Tartrate	89	29
Alendronate Sodium	Alendronate Sodium	88	31
Buspirone Hcl	Buspirone Hcl	81	26
Clopidogrel	Clopidogrel Bisulfate	81	25
Alprazolam	Alprazolam	71	15
Pregabalin	Pregabalin	70	16
Prednisone	Prednisone	69	55
Metformin Hcl Er	Metformin Hcl	67	25
Sertraline Hcl	Sertraline Hcl	66	22
Bupropion Xl	Bupropion Hcl	53	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	16
Escitalopram Oxalate	Escitalopram Oxalate	48	17
Venlafaxine Hcl Er	Venlafaxine Hcl	48	14
Finasteride	Finasteride	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	14
Citalopram Hbr	Citalopram Hydrobromide	43	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	16
Atenolol	Atenolol	41	18
Lovastatin	Lovastatin	41	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	34
Verapamil Er	Verapamil Hcl	40	11
Vitamin D2	Ergocalciferol (Vitamin D2)	40	11
Amitriptyline Hcl	Amitriptyline Hcl	35	13
Gemfibrozil	Gemfibrozil	32	suppressed
Ondansetron Odt	Ondansetron	32	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	14
Glipizide	Glipizide	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	17
Mirtazapine	Mirtazapine	31	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	14
Hydroxyzine Hcl	Hydroxyzine Hcl	30	11
Latanoprost	Latanoprost	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Baclofen	Baclofen	29	11
Clonazepam	Clonazepam	29	suppressed
Entresto	Sacubitril/Valsartan	29	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	13
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Valsartan	Valsartan	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Topiramate	Topiramate	27	suppressed
Telmisartan	Telmisartan	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Famotidine	Famotidine	25	11
Farxiga	Dapagliflozin Propanediol	25	suppressed
Klor-Con M20	Potassium Chloride	25	13
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Levofloxacin	Levofloxacin	24	18
Lorazepam	Lorazepam	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	22
Chlorthalidone	Chlorthalidone	22	11
Colestipol Hcl	Colestipol Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Estradiol	Estradiol	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Folic Acid	Folic Acid	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Azithromycin	Azithromycin	17	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Indapamide	Indapamide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Naproxen	Naproxen	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Nisoldipine	Nisoldipine	13	suppressed
Nystop	Nystatin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error